Hideki Kamiya Selected Research

Dipeptidyl-Peptidase IV Inhibitors

10/2017

Efficacy and Patient Satisfaction of the Weekly DPP-4 Inhibitors Trelagliptin and Omarigliptin in 80 Japanese Patients with Type 2 Diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hideki Kamiya Research Topics

Disease

40	Diabetic Neuropathies (Diabetic Neuropathy) 03/2024 - 09/2002
9	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 12/2004
8	Type 2 Diabetes Mellitus (MODY) 01/2024 - 11/2006
6	Diabetes Complications 01/2023 - 01/2018
4	Diabetes Mellitus 03/2024 - 10/2012
4	Hyperglycemia 01/2024 - 04/2004
3	Neoplasms (Cancer) 11/2020 - 02/2012
3	Polyneuropathies (Polyneuropathy) 10/2020 - 09/2011
3	Insulin Resistance 03/2020 - 05/2009
3	Diabetic Nephropathies (Diabetic Nephropathy) 06/2017 - 05/2015
3	Hyperalgesia 01/2011 - 12/2004
3	hypoglycemic encephalopathy 01/2008 - 04/2004
2	Body Weight (Weight, Body) 01/2023 - 10/2017
2	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2021 - 04/2003
2	Obesity 03/2020 - 10/2012
2	Stroke (Strokes) 08/2010 - 05/2009
2	Atherosclerosis 08/2010 - 05/2009
2	Coronary Disease (Coronary Heart Disease) 08/2010 - 05/2009
2	Cognitive Dysfunction 01/2008 - 04/2004
2	Atrophy 11/2005 - 12/2004
1	Muscular Atrophy (Muscle Atrophy) 01/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Vascular Diseases (Vascular Disease) 10/2020
1	Hypoglycemia (Reactive Hypoglycemia) 10/2019
1	Giant Cell Granuloma (Peripheral Giant Cell Granuloma) 10/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2017
1	Inflammation (Inflammations) 07/2016
1	Pain (Aches) 12/2015
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 09/2015
1	Ketosis 09/2015
1	Hypertension (High Blood Pressure) 05/2015
1	Wounds and Injuries (Trauma) 09/2014
1	Bone Resorption 02/2014

Drug/Important Bio-Agent (IBA)

19	NAD (NADH)IBA 02/2024 - 11/2005
10	Insulin (Novolin)FDA Link 01/2024 - 04/2004
8	Streptozocin (Streptozotocin)FDA Link 01/2021 - 05/2006
7	C-PeptideIBA 01/2023 - 04/2004
5	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 03/2003
5	Aldehyde Reductase (Aldose Reductase)IBA 01/2019 - 09/2002
4	polyolIBA 01/2019 - 09/2002
3	Therapeutic UsesIBA 01/2021 - 09/2019
3	Nerve Growth Factor (NGF)IBA 01/2021 - 10/2008
3	Hypoglycemic Agents (Hypoglycemics)IBA 10/2017 - 09/2015
2	Retinaldehyde (Retinal)IBA 08/2021 - 04/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2020
2	Nerve Growth Factors (Neurotrophins)IBA 01/2020 - 11/2006
2	Conditioned Culture MediaIBA 01/2020 - 09/2019
2	Neuroprotective AgentsIBA 05/2019 - 02/2014
2	epalrestatIBA 01/2019 - 03/2003
2	SodiumIBA 01/2017 - 12/2011
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2017 - 09/2015
2	CreatinineIBA 12/2015 - 08/2010
2	CytokinesIBA 03/2015 - 08/2010
2	ResistinIBA 08/2010 - 05/2009
1	LDL Lipoproteins (beta Lipoproteins)IBA 03/2024
1	Toll-Like Receptor 4IBA 03/2024
1	GlucosidasesIBA 01/2024
1	Blood Glucose (Blood Sugar)IBA 01/2024
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2023
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2023
1	Aspartic Acid (Aspartate)FDA Link 01/2023
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2023
1	Transaminases (Aminotransferases)IBA 01/2023
1	Alanine Transaminase (SGPT)IBA 01/2023
1	IncretinsIBA 11/2020
1	Glucagon (Glukagon)FDA Link 10/2020
1	Peptides (Polypeptides)IBA 10/2020
1	Glycoside Hydrolase InhibitorsIBA 03/2020
1	miglitol (Glyset)FDA Link 03/2020
1	Neutralizing AntibodiesIBA 01/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2019
1	Dapsone FDA Link 10/2019
1	ranirestatIBA 01/2019
1	Glycated Serum AlbuminIBA 10/2017
1	trelagliptinIBA 10/2017
1	2- (2,5- difluorophenyl)- 5- (2- (methylsulfonyl)- 2,6- dihydropyrrolo(3,4- c)pyrazol- 5(4H)- yl)tetrahydro- 2H- pyran- 3- amineIBA 10/2017
1	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2017
1	ipragliflozinIBA 01/2017
1	SymportersIBA 01/2017
1	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 01/2017
1	dapagliflozinIBA 01/2017
1	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 01/2017
1	CanagliflozinIBA 01/2017
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 12/2015
1	Inulin FDA Link 12/2015
1	Pregabalin (Lyrica)FDA Link 12/2015
1	Carboplatin (JM8)FDA LinkGeneric 12/2015
1	Sodium-Glucose Transport ProteinsIBA 09/2015
1	Irbesartan FDA LinkGeneric 05/2015
1	Angiotensin IIIBA 05/2015

Therapy/Procedure

12	Transplantation 01/2021 - 06/2005
5	Therapeutics 01/2024 - 10/2010
3	Drug Therapy (Chemotherapy) 10/2023 - 01/2023
3	Stem Cell Transplantation 01/2021 - 12/2017
2	Cell Transplantation 12/2017 - 03/2015
1	Glycemic Control 01/2023
1	Surgical Amputation (Amputations) 01/2018
1	Secondary Prevention 02/2017
1	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 09/2015